Inventia Life Science is a fast-growing biotechnology startup based in Sydney, Australia, that is revolutionising cancer research, drug discovery and regenerative medicine. Inventia’s digital drop-on-demand 3D bioprinting technology is a game changer for the rapid fabrication of living biological structures. The company’s RASTRUM 3D cell culture platform, winner of the 2019 Good Design Award of the Year and 2020 Fast Company World Changing Ideas Award, has already been adopted in leading medical research institutes creating printed 3D tissues that model real biology. Inventia Life Science is also working with its customers and collaborators on new high-throughput personalised screening approaches as well as with clinical partners to advance regenerative medicine in areas such as bioprinted skin for the repair of burns and wounds.
TRUMPF was founded in 1923 as a series of mechanical workshops and has since developed into one of the world’s leading companies for machine tools, laser technology, and electronics for industrial applications. Our mission is to further develop and digitally connect production technology, to make it even more efficient, precise, and future-proof.
We offer laser sources and flexible laser systems and technology support for micro processing, laser marking, laser cutting and welding, as well as additive manufacturing.
As the most recent strategic segment within Rousselot, we have drawn upon Rousselot’s 125+ years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop X-Pure®, an innovative range of purified gelatins and collagens specifically designed for (bio)medical applications. Offering unique advantages to assure performance, quality and safety, X-Pure is backed by strong scientific data and on-going research. Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help “Advancing medical science”.
The Translational Research Initiative for Cell Engineering and Printing (TRICEP) works with research institutions and industry to develop innovative technologies using 3D bioprinting.
TRICEP can commercialise opportunities in 3D bioprinting including printer manufacturing, biomaterials, bioinks, and material-cellular combinations to address significant industry challenges that require an exclusive, tailored solution.
TRICEP’s world leading research infrastructure can assist companies to bring to life novel technology from concept stage through to prototyping and manufacture of hardware and the formulation of customised bioinks, to accelerate product development and rapidly decrease time to market.
TRICEP is a 100% owned initiative of the University of Wollongong.
Session Sponsor – Fabrication Methods and Technologies / Biofabricated Tissues and Organs
IOP Publishing is a society-owned scientific publisher, providing impact, recognition and value for the scientific community.
Wholly owned by the UK Institute of Physics, we work closely with researchers, academics, and partners worldwide to produce academic journals, ebooks, conference series, and digital products, covering the latest and best research in the physical sciences and beyond.
Session Sponsor – Industry
Established under NCRIS, the Australian National Fabrication Facility (ANFF) provides businesses and academics with open access to more than 500 state-of-the-art micro/nanofabrication facilities spread across 21 Australian locations.
For more than a decade, ANFF has been enabling research through a mixture of training, expert support and direct access.
From proving principles to producing prototypes and beyond, the ANFF network is helping to bring about new generations of:
- bioinks, 3D printers, and materials,
- medical devices,
- and more.
Session Sponsor – Biomaterials/Bioinks/Biopolymers
CollPlant is a regenerative medicine company developing technologies and products for tissue regeneration and organ manufacturing.
CollPlant developed a technology for mass production of rhCollagen in genetically-engineered tobacco plants, which is identical to the collagen produced by the human body.
CollPlant’s product pipeline includes 3D bioprinted implants for breast reconstruction and augmentation, 3D bioprinted surgical mesh for use in breast reconstruction procedures (in collaboration with 3D Systems), and a portfolio of bioinks for various indications.
Session Sponsor – Burster Sessions
Internationally recognised as a leader in electromaterials research, the Intelligent Polymer Research Institute (IPRI) is situated at the state-of-the art Australian Institute for Innovative Materials (AIIM) facility at the University of Wollongong’s Innovation Campus. Established in 1990 by Director Professor Gordon Wallace, IPRI is a key research strength at the University of Wollongong (UOW).
IPRI draws together researchers from a range of disciplines, including biologists, clinicians, chemists, physicists and engineers. IPRI competencies lie in the design and synthesis of intelligent materials. IPRI is renowned for expertise in the group of multifunctional, stimuli-responsive materials – organic conducting polymers and carbons; used in diverse applications of Energy and Health.
Session Sponsor – Evaluation, Characterisation and Quality Control
As Australia’s national science agency and innovation catalyst, CSIRO solves the greatest challenges through innovative science and technology.
We work with organisations large and small, delivering world-leading research and development solutions to help their business innovate, improve and grow.
With 5,000 experts, state-of-the-art facilities, and a global collaborative research network we bring together the best and brightest minds to drive strategic growth and overcome unique business challenges like no other.
Driven to create and facilitate societal, environmental and economic impact, we work with organisations across all major sectors and at all stages of the innovation lifecycle from strategic advice and planning, research and development, through to commercialisation and funding.
CSIRO. Unlocking a better future for everyone.
The University of Wollongong (UOW) is a young and vibrant university with undiminished ambitions and a strong sense of who we are. To confront the challenges of a rapidly changing world we’ve made it our mission to help improve society, through research, innovation and collaboration. From next-gen materials engineering in medicine to tackling superbugs at a molecular level, our research is purposeful and positive.
UOW Researchers are internationally recognised as leaders in electromaterials research, and have made ground-breaking discoveries in Biofabrication. UOW is proud to be positioned as a global leader in research, training and translation in biofabrication. Together with our partners we’re working tirelessly to deliver 3D bioprinting solutions for real world clinical problems.